Vous êtes ici : Accueil > Que faisons-nous ? > Réalisations de 1991 à 2007 > Publications > Publications 2002
Par : jcontent
Publié : 19 juillet 2011

Publications 2002

Wang XM, Wilkin JM, Bois­teau O, Harmegnies D, Blanc C, Vanden­bus­sche P, Monte­ro‑Julian FA, Jacques Y, Content J. Engineering and use of 32P‑labeled human recombinant interleu­kin‑11 for receptor binding studies. Eur J Biochem 269,61‑8,2002.
 
Fikri Y, Pastoret PP, Nyabenda J. Costimulatory molecule requirement for bovine WC1+gammadelta T cells’ proliferative response to bacterial superantigens. Scand J Immunol. 55,373-81,2002.
 
Walravens K, Marche S, Rosseels V, Wellemans V, Boelaert F, Huygen K, Godfroid J.IFN-gamma diagnostic tests in the context of bovine mycobacterial infections in Belgium. Vet Immunol Immunopathol. 87,401-6,2002.
 
Denis O, Stroobant V, Colau D, D’Souza S, Huygen K.Culture filtrate specific H-2(b) restricted CD8+ T cells activated in vivo by Mycobacterium tuberculosis or bovis BCG recognize a restricted number of immunodominant peptides. Immunol Lett. 81,115-24,2002.
 

D’Souza S, Rosseels V, Denis O, Tanghe A, De Smet N, Jurion F, Palfliet K, Castiglioni N, Vanonckelen A, Wheeler C, Huygen K. Improved tuberculosis DNA vaccines by formulation in cationic lipids. Infect Immun.70,3681-8,2002.